Methasteron-Associated Cholestatic Liver Injury: Clinicopathologic Findings in 5 Cases
Authors:
- Isabel ZachariasIZIsabel Zacharias
- Urmila KhettryUKUrmila Khettry
- Nezam AfdhalNANezam Afdhal
- Fredric D. GordonFGFredric D. Gordon
- 1 February 2008
- journal article
- case report
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 6 (2) , 255-258
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Performance-Enhancing Drugs in SportEndocrinology and Metabolism Clinics of North America, 2007
- Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent SuperdrolAmerican Journal of Gastroenterology, 2006
- A Commentary on the American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and RegulationClinical Pharmacology & Therapeutics, 2005
- More Scrutiny for Dietary Supplements?JAMA, 2005
- The Need for Regulation of Dietary Supplements—Lessons From EphedraJAMA, 2003
- Review of oxymetholone: a 17α-alkylated anabolic-androgenic steroidClinical Therapeutics, 2001
- Metabolism of anabolic androgenic steroidsClinical Chemistry, 1996
- Liver pathology associated with the use of anabolic‐androgenic steroidsLiver International, 1992
- Steroids. CV.1 2-Methyl and 2-Hydroxymethylene-androstane DerivativesJournal of the American Chemical Society, 1959